IRIS
BERARDICURTI, ONORINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.871
NA - Nord America 1.621
EU - Europa 793
SA - Sud America 383
AF - Africa 51
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.726
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 2.468
US - Stati Uniti d'America 1.552
CN - Cina 658
HK - Hong Kong 376
IT - Italia 327
BR - Brasile 286
VN - Vietnam 160
FR - Francia 111
GB - Regno Unito 101
DE - Germania 88
IN - India 52
AR - Argentina 34
NL - Olanda 34
CA - Canada 32
ID - Indonesia 27
ES - Italia 24
MX - Messico 24
ZA - Sudafrica 21
TR - Turchia 20
JP - Giappone 19
EC - Ecuador 17
FI - Finlandia 15
UA - Ucraina 15
BD - Bangladesh 14
CO - Colombia 13
IQ - Iraq 12
PL - Polonia 12
MA - Marocco 11
SA - Arabia Saudita 11
CL - Cile 10
PY - Paraguay 9
CZ - Repubblica Ceca 8
AT - Austria 7
RU - Federazione Russa 7
AU - Australia 6
BG - Bulgaria 6
PE - Perù 6
PH - Filippine 6
PK - Pakistan 6
SE - Svezia 6
VE - Venezuela 6
IE - Irlanda 5
IL - Israele 5
LT - Lituania 5
TN - Tunisia 5
DZ - Algeria 4
NP - Nepal 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
EE - Estonia 3
JO - Giordania 3
LV - Lettonia 3
RO - Romania 3
BE - Belgio 2
GR - Grecia 2
GT - Guatemala 2
JM - Giamaica 2
MN - Mongolia 2
OM - Oman 2
RS - Serbia 2
TH - Thailandia 2
TL - Timor Orientale 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
GM - Gambi 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MD - Moldavia 1
MG - Madagascar 1
MM - Myanmar 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.725
Salva come PNG Salva come JPEG
Città #
San Jose 587
Singapore 418
Hong Kong 375
Ashburn 325
Rome 240
Beijing 222
Hefei 202
Boardman 109
Dallas 92
Lauterbourg 92
London 83
Council Bluffs 70
Ho Chi Minh City 67
Shanghai 59
Santa Clara 37
Munich 33
Hanoi 27
Amsterdam 26
São Paulo 23
San Francisco 22
Los Angeles 21
New York 20
Mexico City 16
Pune 16
Frankfurt am Main 15
Washington 14
Bari 13
Tokyo 13
Toronto 13
Naples 12
Warsaw 11
Brooklyn 10
Haiphong 10
Seattle 10
Nuremberg 9
Ankara 8
Guayaquil 8
Jaguariúna 8
Montreal 8
Turku 8
West Jordan 8
Jinan 7
Johannesburg 7
Porto Alegre 7
Boston 6
Brasília 6
Brno 6
Chennai 6
Da Nang 6
Helsinki 6
Hải Dương 6
Atlanta 5
Baghdad 5
Chicago 5
Curitiba 5
Guangzhou 5
Madrid 5
Manchester 5
Stockholm 5
Belo Horizonte 4
Biên Hòa 4
Can Tho 4
Cape Town 4
Dammam 4
Dublin 4
Guarulhos 4
Istanbul 4
Las Vegas 4
Noicattaro 4
Orem 4
Phoenix 4
Rio de Janeiro 4
Riyadh 4
Shijiazhuang 4
Sofia 4
State College 4
Sydney 4
Americana 3
Andradina 3
Bauru 3
Buenos Aires 3
Campinas 3
Changsha 3
Chapecó 3
Cotia 3
Diadema 3
Manaus 3
Medellín 3
Milan 3
Nova Friburgo 3
Rabat 3
Ribeirão Preto 3
Tashkent 3
Tel Aviv 3
Agadir 2
Amman 2
Anantapur 2
Araraquara 2
Arcore 2
Asunción 2
Totale 3.598
Salva come PNG Salva come JPEG
Nome #
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 234
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 220
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 220
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 194
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 164
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 157
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 122
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 122
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 118
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 114
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 113
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 108
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 103
Cytokine storm syndrome in severe COVID-19 103
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 101
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 99
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 96
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 95
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 94
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 89
Cardiovascular disease in primary sjögren’s syndrome 89
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 84
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 83
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 81
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 79
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis 77
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 77
Association Between the Use of Oral Contraceptives and the Development of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 69
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry 68
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach 67
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis 67
Molecular and spatial analysis of tertiary lymphoid structures in Sjogren's syndrome 66
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 66
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 60
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 60
Co-Occurrence of Anti-Synthetase Syndrome and Sjögren Disease: A Case-Based Review 59
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 59
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 58
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 58
Maladaptive Autophagy in the Pathogenesis of Autoimmune Epithelitis in Sjögren's Syndrome 57
Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients 56
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry 55
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 55
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 54
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 53
Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort Study 52
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 51
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 51
Incidence of venous thromboembolism in rheumatoid arthritis, results from a "real-life" cohort and an appraisal of available literature 50
Vitamin D and systemic lupus erythematosus - The hype and the hope 50
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 50
From pain catastrophising to multidimensional psychological distress: unravelling the complexity of difficult-to-treat psoriatic arthritis 49
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 49
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 48
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 47
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease Registry 47
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 47
The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: Implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study 47
Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction 47
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 46
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 46
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 46
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 46
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile 46
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm 45
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 45
Peripheral Nervous System Involvement in Sjögren's Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren's Syndrome 45
The Relationship Between Metabolic Syndrome and Pain Catastrophizing in Psoriatic Arthritis 44
The clinical heterogeneity of adult onset Still's disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients 44
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 44
Interstitial lung disease in systemic sclerosis: current and future treatment. 43
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 43
Rheumatic manifestations of COVID-19: a systematic review and meta-analysis 42
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 42
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 42
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 42
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 42
Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome 41
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 41
Endothelial-to-mesenchymal transition in systemic sclerosis 41
The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease 40
Glucocorticoids in Rheumatoid Arthritis: The Silent Companion in the Therapeutic Strategy 40
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 40
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 40
Is minor salivary gland biopsy still mandatory in Sjogren's syndrome? Does seronegative Sjogren's syndrome exist? 39
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 39
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 39
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 38
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 38
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 38
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features 37
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 37
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 36
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 34
Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry 33
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 33
Dissecting the clinical heterogeneity of adult-onset Still's disease: results from a multi-dimensional characterization and stratification 33
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 32
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 31
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study 31
Totale 6.652
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.129
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022111 0 0 2 0 0 0 0 0 18 4 5 82
2022/202398 1 2 2 4 15 1 2 8 3 5 54 1
2023/2024339 16 35 15 40 40 139 7 10 3 13 13 8
2024/20252.948 48 44 117 29 30 72 71 32 252 252 784 1.217
2025/20263.295 345 144 259 432 141 191 974 264 273 272 0 0
Totale 6.791